Business
Simulations Plus Reports Fourth Quarter and Fiscal 2025 Financial Results
RESEARCH TRIANGLE PARK, N.C., December 01, 2025--Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in cheminformatics, biosimulation, clinical operations solutions and medical communications that accelerate biopharma innovation, today reported financial results for its fourth quarter and fiscal 2025, ended August 31, 2025.
About this update from Simulations Plus, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/6e3d44e022ceba78121299063e4bc4d2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/09frc6q5PQ1HFHQIZQATSw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTk2MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/6e3d44e022ceba78121299063e4bc4d2","width":480,"height":480}},"lazy":false},{"type":"text","content":"Reaffirms fiscal 2026 revenue guidance of $79 to $82 million and adjusted diluted EPS guidance of $1.03 to $1.10","length":112,"tagName":"p","attribs":{}},{"type":"text","content":"Investor Day on January 21, 2026, to present new product vision and AI solutions ","length":80,"tagName":"p","attribs":{}},{"type":"text","content":"RESEARCH TRIANGLE PARK, N.C., December 01, 2025--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in cheminformatics, biosimulation, clinical operations solutions and medical communications that accelerate biopharma innovation, today reported financial results for its fourth quarter and fiscal 2025, ended August 31, 2025.","length":403,"tagName":"p"},{"type":"text","content":"Fourth Quarter 2025 Financial Highlights (as compared to fourth quarter 2024)","length":77,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Total revenue decreased 6% to $17.5 million","length":43,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Software revenue decreased 9% to $9.0 million, representing 52% of total revenue","length":80,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Services revenue decreased 3% to $8.4 million, representing 48% of total revenue","length":80,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Gross profit was $9.8 million; gross margin was 56%","length":51,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Net loss of $0.7 million and diluted loss per share of $0.03, compared to net income of $0.8 million and diluted EPS of $0.04","length":125,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Adjusted EBITDA of $3.5 million, representing 20% of total revenue, compared to $4.1 million, representing 22% of total revenue","length":127...